Delfi Limited

Broker's Calls

RHB initiates ‘buy’ on Delfi, calling it a ‘strong Indonesia consumer play’

Delfi may be a potential takeover target due to its market leadership and full market coverage in Indonesia: RHB.

Broker's Calls

UOBKH adds Marco Polo Marine and RH Petrogas, removes Delfi, LHN Group and Yangzijiang from October alpha picks

UOBKH’s alpha picks portfolio beat the STI by 4.7 ppts, “overcoming weak investor sentiment in September”.

Broker's Calls

Brokers' Digest: CDL, Centurion, Food Empire, Delfi, Nanofilm, AEM

See what the analysts have to say this week.
Delfi to benefit from Indonesia's strong retail sales index: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Delfi to benefit from Indonesia's strong retail sales index: CGS-CIMB

Analysts say Delfi’s 1QFY2023 results have been in line with consensus, but cite a lack of visibility on cost management ahead.
Stocks like Delfi, Marco Polo Marine and Raffles Medical could benefit from Indonesia's strong economic performance - THE EDGE SINGAPORE

Broker's Calls

Stocks like Delfi, Marco Polo Marine and Raffles Medical could benefit from Indonesia's strong economic performance

The sectors to look out for are consumer, commodity, healthcare tourism, plantation and marine-related.

Results

Delfi reports 24.5% y-o-y growth in 1QFY2023 ebitda of US$25.5 mil

Revenue for the quarter rose by 20.8% y-o-y to US$160.8 million as revenue improved across the board.

Broker's Calls

UOBKH sees continued growth momentum for Delfi in 2023, keeps buy call at TP of $1.71

UOBKH sees continued growth momentum for Delfi in 2023, keeps buy call at TP of $1.71

Broker's Calls

Strong demand for sweet treats: Analysts at Lim & Tan Securities lift Delfi’s TP

Strong demand for sweet treats: Analysts at Lim & Tan Securities lift Delfi’s TP
×